Mankind Pharma IPO Day 2- Issue subscribed 87%; QIBs, NIIs overbid for their portion
时间:2024-06-26 09:18:33 阅读(143)
Mankind Pharma IPO opened for subscription on 25 April and the issue has been booked 0.87 times on day 2, with total bids of 2,45,19,352 shares. Qualified institutional buyers (QIBs) subscribed for 186% of their reserved portion, demonstrating high interest in the issue. Retail investors bid only 0.25 times of the shares reserved for RIIs. The NII portion garnered 102% bids so far. The IPO closes for subscription on Thursday, 27 April.
Mankind Pharma shares’ GMP fell to Rs 30 on Wednesday, compared to Rs 92 per equity share on Monday. The GMP indicated the shares are valued 2.78% over the upper end of the share price on offer. The price band for its public issue at Rs 1,026-1,080 per equity share of face value Re 1 each. At the upper end of the price band, the company’s promoters and shareholders seek to raise Rs 4,326.35 crore from the IPO.
“At the upper price band of Rs 1,080, MPL is available at a P/E of 30x (FY22), which appears reasonably priced compared to peers. Considering under-penetration of healthcare services and lower consumer expenditure in healthcare in India, MPL’s focus on chronic therapeutic areas, emphasis on increasing penetration in metro and Class I cities, growth in consumer healthcare business, good financial performance and strong distribution network, we assign a “Subscribe” rating on a long term basis,” said Geojit Financial Services, recommending investors subscribe to the issue.
猜你喜欢
- t to note that like all asset classes, Gold prices are also affected by several factors and tend to have a period of outperformance and underperformance and periods of higher volatility. You need to have Demat and trading accounts to invest in exchange-traded funds.
(Siddharth Srivastava is Head – ETF Product, Mirae Asset Mutual Fund. The views expressed in the article are of the author and do not reflect the official position or policy of FinancialExpress.com.)
- The Future of Insurance- Embracing Technology to Meet Customers’ Needs
- Global markets- Asia shares take comfort in China property rally
- Top-10 most valued firms lose over Rs 2
- Bank Nifty Highlights- Nifty Bank F&O expiry shifts to Friday; index ends above 44150, Kotak Bank gains, Federal Bank falls
- Gold Price Today, 16 Dec 2022- Prices flat, dollar rises; yellow metal set for weekly loss amid hawkish US Fed
- Gold outlook- MCX gold sentiment shifts to bullish trend; buy yellow metal for dip near Rs 50700
- Gold Price Today, 12 Dec 2022- Prices fall as dollar strengthens; traders eye US inflation, Fed rate decision
- Thousands evacuated as devastating floods hit northeastern China – In pics